2016 MassBio Industry Snapshot
The number of drug candidates in clinical trials from Massachusetts-headquartered companies increased by 14% from 2014, and the total number of drug candidates increased to 1,645, a 10% increase, according to an annual industry report published by MassBio.
Massachusetts researchers are currently researching and developing products for patients with 362 different medical indications. Oncology drugs make up 36% of that pipeline with systemic anti-infectives, central nervous system, and musculoskeletal therapeutic areas as other strong areas of research. The Massachusetts drug development pipeline includes 13 candidates that are pending FDA approval.
The 2016 MassBio Industry Snapshot shows that in the last 10 years, Massachusetts biopharma manufacturing employment has grown by 34% to 10,616 jobs statewide. In the same time period, the United States lost 24,000 biopharma manufacturing jobs, a 7.9% decrease. Massachusetts biomanufacturing employment grew by 6.3% year over year, outpacing other industry subsectors in 2015, including research and development.